Abstract
Increasing body of experimental evidence suggests that anticancer and antimicrobial therapies may themselves promote the acquisition of drug resistance by increasing mutability. The successful control of evolving populations requires that such biological costs of control are identified, quantified and included to the evolutionarily informed treatment protocol. Here we identify, characterise and exploit a trade-off between decreasing the target population size and generating a surplus of treatment-induced rescue mutations. We show that the probability of cure is maximized at an intermediate dosage, below the drug concentration yielding maximal population decay, suggesting that treatment outcomes may in some cases be substantially improved by less aggressive treatment strategies. We also provide a general analytical relationship that implicitly links growth rate, pharmacodynamics and dose-dependent mutation rate to an optimal control law. Our results highlight the important, but often neglected, role of fundamental eco-evolutionary costs of control. These costs can often lead to situations, where decreasing the cumulative drug dosage may be preferable even when the objective of the treatment is elimination, and not containment. Taken together, our results thus add to the ongoing criticism of the standard practice of administering aggressive, high-dose therapies and motivate further experimental and clinical investigation of the mutagenicity and other hidden collateral costs of therapies.
Publisher
Public Library of Science (PLoS)
Subject
Computational Theory and Mathematics,Cellular and Molecular Neuroscience,Genetics,Molecular Biology,Ecology,Modelling and Simulation,Ecology, Evolution, Behavior and Systematics
Reference56 articles.
1. Evolutionary rescue: An emerging focus at the intersection between ecology and evolution;A Gonzalez;Philosophical Transactions of the Royal Society B: Biological Sciences,2013
2. Evolutionary rescue: Linking theory for conservation and medicine;HK Alexander;Evolutionary Applications,2014
3. Evolutionary rescue over a fitness landscape;Y Anciaux;Genetics,2018
4. The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy;AF Read;Proceedings of the National Academy of Sciences of the United States of America,2011
5. The Genetic Origin of Drug Resistance in Neoplasms: Implications for Systemic Therapy;JH Goldie;Cancer Research,1984
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献